Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Return on Equity (2016 - 2025)

Historic Return on Equity for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to 0.16%.

  • Angiodynamics' Return on Equity rose 10200.0% to 0.16% in Q4 2025 from the same period last year, while for Nov 2025 it was 0.16%, marking a year-over-year increase of 10200.0%. This contributed to the annual value of 0.17% for FY2025, which is 4600.0% up from last year.
  • According to the latest figures from Q4 2025, Angiodynamics' Return on Equity is 0.16%, which was up 10200.0% from 0.18% recorded in Q3 2025.
  • Over the past 5 years, Angiodynamics' Return on Equity peaked at 0.02% during Q3 2023, and registered a low of 1.21% during Q3 2024.
  • Its 5-year average for Return on Equity is 0.27%, with a median of 0.09% in 2022.
  • Per our database at Business Quant, Angiodynamics' Return on Equity plummeted by -12200bps in 2024 and then surged by 10300bps in 2025.
  • Angiodynamics' Return on Equity (Quarter) stood at 0.09% in 2021, then increased by 10bps to 0.08% in 2022, then surged by 57bps to 0.03% in 2023, then tumbled by -3343bps to 1.17% in 2024, then surged by 87bps to 0.16% in 2025.
  • Its Return on Equity stands at 0.16% for Q4 2025, versus 0.18% for Q3 2025 and 0.18% for Q2 2025.